

Day One Biopharmaceuticals, a provider of targeted therapies for children and adults with cancer, has raised $130 million in Series B financing. RA Capital Management led the round.
Source: Press Release
Day One Biopharmaceuticals, a provider of targeted therapies for children and adults with cancer, has raised $130 million in Series B financing.
Day One Biopharmaceuticals, a provider of targeted therapies for children and adults with cancer, has raised $130 million in Series B financing. RA Capital Management led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination